Molecular NeuroImaging is a clinical research site located in New Haven, Connecticut, United States 06510.
Crixeo Clinical Trials Trust Score: 23/100 (FAILING). This profile has not yet been claimed by the site owner.
Molecular NeuroImaging has participated in 26 clinical trials.
Therapeutic areas: Alzheimer Disease, Healthy Volunteers, Progressive Supranuclear Palsy.
Sponsors: Navidea Biopharmaceuticals, Molecular NeuroImaging, Sumitomo Pharma America, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Connecticut · View every site in New Haven
Trust Score: 23/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Molecular NeuroImaging has a Crixeo Trust Score of 23/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Molecular NeuroImaging has 26 clinical trials on record. Their work covers Alzheimer Disease, Healthy Volunteers, Progressive Supranuclear Palsy.
Molecular NeuroImaging has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.